First Hawaiian Bank Decreases Holdings in MetLife, Inc. (NYSE:MET)

First Hawaiian Bank lessened its stake in shares of MetLife, Inc. (NYSE:METFree Report) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 70,671 shares of the financial services provider’s stock after selling 2,090 shares during the period. First Hawaiian Bank’s holdings in MetLife were worth $4,673,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in MET. Synovus Financial Corp increased its holdings in MetLife by 11.4% during the first quarter. Synovus Financial Corp now owns 17,847 shares of the financial services provider’s stock worth $1,260,000 after buying an additional 1,829 shares during the last quarter. Brighton Jones LLC purchased a new stake in MetLife during the first quarter worth about $225,000. Baird Financial Group Inc. increased its stake in shares of MetLife by 179.7% in the first quarter. Baird Financial Group Inc. now owns 540,081 shares of the financial services provider’s stock worth $37,957,000 after purchasing an additional 346,999 shares in the last quarter. Zions Bancorporation N.A. raised its position in shares of MetLife by 937.3% in the first quarter. Zions Bancorporation N.A. now owns 5,861 shares of the financial services provider’s stock valued at $412,000 after purchasing an additional 5,296 shares during the period. Finally, Brown Brothers Harriman & Co. raised its position in shares of MetLife by 114.5% in the first quarter. Brown Brothers Harriman & Co. now owns 3,419 shares of the financial services provider’s stock valued at $240,000 after purchasing an additional 1,825 shares during the period. Hedge funds and other institutional investors own 88.14% of the company’s stock.

Insider Activity

In other news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is owned by corporate insiders.

MetLife Price Performance

MET stock traded up $0.49 during midday trading on Friday, reaching $72.39. The company had a trading volume of 5,758,087 shares, compared to its average volume of 3,940,309. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1 year low of $48.95 and a 1 year high of $72.89. The company has a market capitalization of $52.34 billion, a P/E ratio of 39.56, a P/E/G ratio of 0.55 and a beta of 1.03. The firm has a 50-day moving average price of $69.20 and a 200-day moving average price of $65.32.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The company had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. On average, research analysts anticipate that MetLife, Inc. will post 8.81 earnings per share for the current fiscal year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 14th. Stockholders of record on Tuesday, February 6th were paid a $0.52 dividend. The ex-dividend date of this dividend was Monday, February 5th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.87%. MetLife’s dividend payout ratio (DPR) is 113.66%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Keefe, Bruyette & Woods lowered their price target on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a research report on Thursday, December 7th. UBS Group lowered their price target on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research report on Monday, February 5th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and boosted their price target for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Wells Fargo & Company reduced their price objective on shares of MetLife from $85.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, February 6th. Finally, Barclays reaffirmed an “overweight” rating and set a $71.00 price objective on shares of MetLife in a research note on Friday, November 17th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $77.23.

Check Out Our Latest Research Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.